Brown Advisory Reduces $40M in Establishment Labs Holdings Inc. ($ESTA)
Key Points
- Brown Advisory changed its Establishment Labs Holdings Inc. ($ESTA) stake by 23.4% last quarter, cutting to 1,526,872 shares worth $129.95 million.
- Wall Street's consensus rating on $ESTA is Strong Buy and an average price target of $90.11.
- $ESTA last traded around $85.11.
Brown Advisory reduced its position in Establishment Labs Holdings Inc. ($ESTA) by 23.4% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,526,872 shares of Establishment Labs Holdings Inc. after selling 467,426 shares during the quarter. Brown Advisory's holdings in Establishment Labs Holdings Inc. were worth $129.95 million as of its most recent filing.
Establishment Labs Holdings Inc. ($ESTA) Stock
Establishment Labs Holdings Inc. Earnings
Analysts Set New Price Targets
About Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.